Jeff Fischer, MBA

Co-founder and President of Longhorn Vaccines and Diagnostics.

Articles

Longhorn Vaccines Develops Sepsis Vaccine Targeting Key Toxins

November 8th 2024

This composite peptide vaccine targets key bacterial toxins to prevent sepsis, enhance antibiotic efficacy, reduce inflammation in diseases and cancer, with further data expected soon.

New Peptide Vaccine for Universal Influenza Protection

Sophia Abene;Jeff Fischer, MBA

November 5th 2024

New approach targets multiple strains, promising broad protection against human, avian, and swine influenza viruses.

Published: August 27th 2024 | Updated: August 28th 2024

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties

Published: March 9th 2022 | Updated: December 21st 2024

Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance

Published: December 5th 2024 | Updated: December 21st 2024

COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population

Published: December 19th 2024 | Updated: December 21st 2024

COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?

Published: December 17th 2024 | Updated: December 21st 2024

Peer-Assisted Telemedicine Enables More People With Hepatitis C to Get into the Continuum of Care

Published: December 18th 2024 | Updated: December 21st 2024

Ethical and Innovative Use of AI in Infectious Disease

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Jeff Fischer, MBA

Articles

Latest Updated Articles